152. Crystals in the Cosmos: Varda Rewrites Drug Formulation in Microgravity

Episode notes

In this episode, we explore how Varda Space Industries is pioneering pharmaceutical manufacturing in microgravity with Chief Strategy Officer Michael Riley and Chief Science Officer Adrian Radocea. The team discusses how removing gravity from the crystallization process enables better drug formulations - creating more stable, bioavailable medicines that don't require refrigeration. From their reusable spacecraft that can manufacture drugs in orbit and return them to Earth, to their vision of making space-based manufacturing routine and "boring," Varda is bridging aerospace engineering and biopharma to solve formulation challenges that have stumped the industry for decades. With $187 million in recent funding and spacecraft currently in orbit, they're transforming science fiction into a manufacturing platform that could expand access to medicines globally. Chapters: (00:00:00) Teaser and Introduction (00:05:00) Meet the Team: From Semiconductors and Global Health to Space Pharma (00:08:00) Microgravity as a Manufacturing Tool: Physics Over Chemistry (00:13:00) Which Drugs Benefit Most?

• 186. N.Y. Tech Week Live Demo: Engineering the Future of Manufacturing with Roebling's Brentan Alexander72 / 100
• 185. Brick Happens: Chris Maurer of Redhouse Studio Redesigns Remote Living for Earth and Mars75 / 100
• 184. The Multiverse of Microbes: Henry Lee on Building Cultivarium and Training with Titans65 / 100
• 183. The American Biotech Blueprint: Senator Todd Young on Biodiversity as National Security
• 182. SynBioBeta 2026 Recap, It's Biologist Approved